Timegadine

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C20H23N5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1XR74J44UL, chemically known as guanidine, n-cyclohexyl-n-(2-methyl-4-quinolinyl)-n-2-thiazolyl- but generally known as timegadine, which bears US NIH Compound Identifier 68902. European Medicines Agency schedules Timegadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11062MIG. The term TIMEGADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). TIMEGADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule timegadine under HS 29341000 and SITC 51579. As of Q4 2014, TIMEGADINE remains the US FDA Preferred Term for this commodity. Timegadine bears US NLM identifiers UMLS ID C0076684 and NCI Concept Code C90909. SMILES: S1C(NC(=N\C2CCCCC2)/NC2C3C(NC(C2)C)CCCC3)NCC1.